Figure 3 illustrates the within‐ and between‐group comparison of hs‐CRP serum levels (mg/L) of MS patients before and after the omega‐3 fatty acids supplementation and placebo administration. The gene discussed is MAP3K14; the disease is myeloid sarcoma.